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Abstract: Osmolytes are small molecules that are exploited by cells as a protective system 
against stress conditions. They favour compact protein states which makes them stabilize 
globular proteins in vitro and promote folding. Conversely, this preference for compact 
states promotes aggregation of unstructured proteins. Here we combine a brief review of 
the effect of osmolytes on protein fibrillation with a report of the effect of osmolytes on the 
unstructured peptide hormone glucagon. Our results show that osmolytes either accelerate 
the fibrillation kinetics or leave them unaffected, with the exception of the osmolyte 
taurine. Furthermore, the osmolytes that affected the shape of the fibrillation time profile 
led to fibrils with different structure as revealed by CD. The structural changes induced by 
Pro, Ser and choline-O-sulfate could be due to specific osmolytes binding to the peptides, 
stabilizing an otherwise labile fibrillation intermediate.  
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1. Introduction 
1.1. Osmolytes: Chemical Chaperones Which Can Stabilize or Destabilize Proteins 
Osmolytes are small organic molecules that have evolved throughout various taxa and increase the 
ability of cells to react to osmotic stress. In contrast to inorganic ions, which can also be used for 
adaptation to extracellular stress, osmolytes do not negatively interfere with structure or function of 
biological macromolecules. For example, inorganic ions have been shown to reduce enzymatic activity 
in the case of phosphoenolpyruvate (PEP) for pyruvatekinase (PK) of the crab, while osmolytes do not 
interfere with its activity [1]. Similarly, the disruption of the native myofilament architecture induced 
by KC1 and NaCI can be prevented by addition of the osmolyte trimethyl amine oxide (TMAO) [2]. 
Most osmolyte compounds can be divided into three chemical classes: polyhydric alcohols and sugars 
(polyols), amino acids and their derivatives and methyl ammonium compounds [3]. Osmolytes are 
widely used to stabilize and facilitate protein folding since they can act as “chemical chaperones” [4,5]. 
For many proteins, the melting temperature Tm increases with the addition of osmolytes in a 
concentration-dependent manner [3,5]. Osmolytes are generally thought to act by preferential surface 
exclusion. This means that they destabilize expanded states such as the unfolded state to a greater 
extent than more compact states (e.g., the native state) [6,7]. Thus in practice osmolytes stabilize 
globular proteins by favouring compaction. However, this phenomenon can be a disadvantage in the 
case of intrinsically disordered proteins where compaction can promote intermolecular aggregation. 
Note however that osmolytes, depending on solvent conditions can also decrease protein melting 
temperatures [8]. This is not too surprising, as evolutionary selection will favour the production of 
osmolytes only if they lead to enhanced protein function at ambient temperature. There is no 
evolutionary pressure for increased stability at physiologically irrelevant elevated temperatures. As a 
result, some osmolytes thermodynamically destabilize folded proteins but reduce aggregation at the 
same time, the most prominent example being urea [9,10]. This osmolyte, widely used for its 
destabilizing effects for protein stability and folding studies in vitro, is used by many organisms in 
combination with methylamines (ratio 2:1) for an optimal functionality of its enzymes [11]. It is 
therefore important to distinguish between “stabilization effects” that act on Tm and those that act on 
aggregation kinetics. Similarly, an increase in Tm does not necessarily relate to the reversibility of the 
folding process. For example, the Tm of lysozyme unfolding can be increased by 22 °C by addition of 
sarcosine, but as complete unfolding takes place even in the presence of osmolyte, the protein 
aggregates irreversibly, while other proteins retain their reversible unfolding [12]. 
Note also that most studies on osmolytes investigate their effect on thermodynamic stability [7,13]. 
This does not necessarily correlate with “stabilization” in the sense of preserving functionality over 
extended periods. The latter can result partially or completely from kinetic inhibition of aggregation 
and may have a large impact in industrial applications. Data about osmolytes affecting kinetic stability 
are scarce: Nayak et al. [14] determined fibrillation and nucleation rate constants of insulin in the 
presence of polyols. Osmolyte influence on RNAse A enzymatic function has been reported by   
Jamal et al. [15]. However, the molecular processes leading to the changes in Km and kcat were not 
established.  Int. J. Mol. Sci. 2012, 13 
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One parameter strongly influencing osmolyte impact is pH. According to Singh et al. [8], polyols 
show a more potent stabilizing effect towards proteins’ native state at low pH. A possible explanation 
would be that at low pH, carboxyl groups in Glu and Asp become protonated, making hydrogen bonds 
with polyols less favorable than at high pH, where carboxyl groups are deprotonated and negatively 
charged. As a result preferential surface exclusion of polyols and consequent protein stabilization 
increases at low pH [16]. The stabilizing effect of methylamines on the other hand has been found to 
be most pronounced at neutral pH, while they can be destabilizing at low pH. [15]. This observation 
has been attributed to the fact that at neutral pH, zwitterionic methylamines are excluded from the 
protein surface, i.e., act as stabilizers, while in their positively charged form at low pH, they will 
directly interact with the protein backbone, preferentially stabilizing the denatured state and decreasing 
the free energy of unfolding ΔGD-N. This effect has been described for TMAO and Betaine [17–19].  
A similar effect would be expected for amino acids and their derivatives. However, those compounds 
were found to stabilize the native state proteins almost independent of pH. It appears that here,   
effects of pH on ΔGD-N resulting from direct protein-osmolyte interaction and surface exclusion are 
balanced [15]. Protein destabilization may also occur at very high osmolyte concentrations [12,20], 
where the modestly favorable interactions between apolar parts of the osmolyte and hydrophobic side 
chains become more significant, resulting in exposure of hydrophobic residues and unfolding [12].  
The mechanistic bases for other properties of osmolytes are still subject to debate: For instance,   
it was reported that higher molecular weight polyols stabilize proteins better than their low MW 
counterparts [21]. There are also clear indications that part of the action of osmolytes can be   
protein-specific: e.g., glycine betaine at physiological pH strongly stabilizes RNase A but leads to 
aggregation or partial unfolding of green fluorescent protein [18,19]. 
1.2. Osmolytes and Protein Fibrillation 
Despite the large number of studies investigating the effect of osmolytes on protein folding, few 
investigations have been performed on the effect of osmolytes on protein fibrillation. Here we provide 
a brief review of the published work on the topic. We emphasize that the paucity of systematic 
investigations makes it difficult to make generalizations about the impact of different osmolyte classes 
on the fibrillation process, and we hope that the present work (see below) may inspire further work to 
mitigate this state of affairs. 
In general it is difficult to predict how osmolytes affect protein aggregation. Some osmolytes such 
as amino acids and methylamines, may bind relatively strongly to proteins or can alter protein hydration 
patterns and may thus influence protein-protein interactions and the structure of the ensuing aggregate, 
which can vary from oligomer(s) to fibrils to amorphous aggregates. TMAO for example, induces Aβ 
oligomerization but encourages tau fibrillation [22] though both proteins are natively unfolded.  
For globular proteins, destabilization of the most expanded state leads to correct folding, while in 
the case of intrinsically disordered proteins (IDPs) the same process can promote aggregation. This can 
occur in two situations. Aggregation of the IDP sometimes requires formation of a compact monomeric 
state that contains elements of structure favoring intermolecular contacts (cfr. the stimulation of 
aggregation of the IDP α-synuclein by salts and low pH [23] and similar observations for other 
proteins [22,24]). Alternatively, the oligomeric or fibrillar state is simply favored because it is more Int. J. Mol. Sci. 2012, 13 
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compact than the exposed denatured state. An example of such an effect is given by the amino acid 
proline. This osmolyte inhibits aggregation of globular proteins such as lysozyme [25] and P39A 
cellular retinoic acid-binding protein [26], while mutant huntingtin exon 1 aggregates into amorphous 
aggregates [27] and we report that Pro promotes fibrillation of glucagon (see below).  
The intrinsically disordered protein α-synuclein, involved in Parkinson’s Disease, forms a relatively 
heterogeneous ensemble of compact oligomeric structures in the presence of 3 M TMAO, while at 
lower TMAO concentrations the formation of a partially folded intermediate accelerates fibrillation [28]. 
Similarly, 1 M glucose induces collapse of α-synuclein [29] (Table 1). TMAO also accelerates the 
fibrillation of S-carboxymethylated  α-lactalbumin [30] and induces oligomerization of the prion 
protein [31] but inhibits conversion to the amyloidogenic form of the prion protein in vivo [32]. 
Oligomerization by TMAO is also observed for the amyloid β peptide Aβ involved in Alzheimer’s 
Disease [33], and TMAO increases the secondary structure content of the flexible and prion-determining 
region of Sup35p [34].  
The fact that osmolytes can inhibit fibrillation but induce oligomerization should be taken into 
account if the ultimate purpose is a reduction or complete inhibition of the aggregates’ toxicity: in all 
cases, the properties of the ensuing aggregates have to be studied in detail. A good example is provided 
by Aβ. Galactose and mannose induce the aggregation of Aβ40 and Aβ42 into mature fibrils, while 
glucose, sucrose and fructose make them oligomerize [24]. Other osmolytes, such as glycine and 
taurine, accelerate Aβ40 fibril formation [35] while trehalose completely inhibits its aggregation.   
As for Aβ42, 50 mM trehalose makes the peptide form toxic oligomers [36] while 250 mM trehalose 
makes it fibrillate slower than in the absence of chemical chaperones [37]. Other studies instead 
reported lower toxicity and reduced protein aggregation in the presence of trehalose in vivo [38,39]. 
Several osmolytes have been reported to inhibit fibrillation, while favouring the formation of 
oligomers or amorphous aggregates in the case of intrinsically disordered proteins (Table 1). This 
could be due to the general mechanism of destabilization of the unfolded state caused by the 
preferential exclusion from the protein surface, together with possible protein-specific interactions. In 
this context the amorphous aggregates induced by the osmolytes represent an alternative way to render 
the protein compact, which may prevail over fibrillar aggregates for reasons of kinetic accessibility.  
A cautionary note is required regarding the use of ThT fluorescence intensities to quantify the 
amount of formed fibrils, as presented in [36,40]. In fact, ThT fluorescence intensity could potentially 
be affected by interactions between ThT and the osmolyte, which is always present at many   
thousand-fold higher concentrations than ThT, as well as by competitive osmolyte binding on the fibril 
surface [41,42]. Furthermore, osmolytes can induce fibrillar polymorphism, as we report for glucagon 
(see below). In this case, ThT intensities are influenced by the fibrils’ morphology [43] and therefore 
cannot be used to quantify the amount of peptide in the fibrillar form. For these reasons, control 
experiments to evaluate possible fluorescence quenching effects and parallel use of complementary 
techniques to evaluate the amount of fibrillated material (e.g., centrifugation to determine the amount 
of aggregated protein and CD/FTIR to ascertain possible changes in structure) are always recommended. 
 Int. J. Mol. Sci. 2012, 13 
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Table 1. Effect of osmolytes addition to several fibrillating proteins.  
Osmolyte Aβ40 Aβ42  α-synuclein polyQ 
Immunoglobulin 
light chains 
Glucagon 
1  insulin lysozyme 
Glucose  oligomerization [24]  oligomerization [24]  collapse  no effect  minor effect [14] 
Sucrose  oligomerization [24]  oligomerization [24] 
    
no effect 
no/minor effect 
[14,44] 
reduced aggregation 
[25,45] 
Fructose  no effect[24]  no effect [24]  minor effect [14] 
Galactose 
induced fibrillation 
[24] 
induced fibrillation 
[24]           
Mannose 
induced fibrillation 
[24] 
induced fibrillation 
[24]           
Sorbitol 
     
longer lag, more 
stable fibrils [46] 
no effect 
  
Glycerol  oligomerization [33]          no effect    no effect [25] 
Trehalose 
slower/no 
fibrillation [36,37] 
oligomerization 
(toxic) [36]   
reduced 
aggregation in 
mice [47] 
 
no effect 
reduced/slower 
fibrillation 
[14,44] 
increasing B
1 [48], 
reduced aggregation [45] 
Gly 
faster fibrillation 
[35]       
faster 
fibrilation  
no effect [25] 
Pro 
   
amorphous 
aggregates [27]   
polymorphism 
 
inhibits aggregation [25] 
Taurine 
faster fibrillation 
[35]       
slower 
fibrillation    
Ectoine 
 
longer lag time, 
more oligomers, 
lower toxicity[40] 
    
faster 
fibrilation 
highly reduced 
fibrillation [44]   Int. J. Mol. Sci. 2012, 13 
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Table 1. Cont. 
Osmolyte Aβ40 Aβ42  α-synuclein polyQ 
Immunoglobulin 
light chains 
Glucagon 
1  insulin lysozyme 
Betaine 
   
faster fibrillation 
[27] 
longer lag, more 
stable fibrils [46] 
faster 
fibrilation 
highly reduced 
fibrillation [44] 
increasing B
2 [48] 
Sarcosine 
       
faster 
fibrillation, 
polymorphism 
 
Tm of unfolding 
increases by 22°, but the 
unfolded lysozyme 
aggregates [12] 
TMAO 
little effect [37]; 
oligomerization [33]   
folded 
oligomer/ 
enhanced 
fibrillation 
[28] 
amorphous 
aggregates [27]         
Notes: 
1 Based on results in this study. 
2 B: osmotic second virial coefficient. An increasing value means more attractive forces between molecules. 
 Int. J. Mol. Sci. 2012, 13 
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1.3. Glucagon: A Model System for Fibrillation 
As a complete and systematic study of the effects of osmolytes on intrinsically disordered proteins 
is lacking, we performed a study on the natively unfolded peptide glucagon in which we compare the 
effects of many osmolytes belonging to the three different classes. Glucagon is an intrinsically 
disordered peptide hormone, which has been shown to readily fibrillate in vitro into fibrillar aggregates 
with different structure and morphology depending on the conditions used for fibrillation, such as 
protein concentration and salt [49]. Under acidic conditions, glucagon fibrillation is particularly 
sensitive to the presence of anions, with effects following the electroselectivity series, rather than the 
Hofmeister series. In particular, addition of sulfates results in faster fibrillation into a stable fibrillar 
structure showing an “α-like” CD spectrum. Our results confirm that proteins lacking a globular 
structure can aggregate more easily in the presence of osmolytes and that these cosolutes can affect 
glucagon fibrils’ structure.  
2. Results 
2.1. Glucagon Fibrillation Is Either Accelerated or Unaffected by Osmolytes  
Here we describe a systematic study of the effects of osmolytes on glucagon fibrillation.   
A representative sample of osmolytes was selected from Table (6.1) in Hochachka et al. [50].  
For the polyols class we present results for trehalose, sucrose, mannitol, sorbitol, erythritol, glucose,  
myo-inositol and glycerol; for the class containing the amino acids and their derivatives we present 
results for Pro, Ala, Gly, Ser, taurine, ectoine and OH-ectoine; for the methylamines class we report 
data for glycine betaine, sarcosine and choline-O-sulfate (COS). 
To explore the kinetics of glucagon fibrillation in the presence of osmolytes, ThT emission was 
measured over time for samples with a constant glucagon concentration (1 mg/mL) and 125–400 mM 
osmolytes. The raw ThT data immediately show that no osmolyte was able to inhibit glucagon 
fibrillation. Figure 1 shows the effect of including 125 mM osmolyte in the glucagon solution on the 
fibrillation lag time. The sugars and polyols class generally show very little effect on the lag time of 
fibrillation. The amino acids class generally reduce the lag time, particularly Ala, Gly and Ser. Pro has 
a very modest effect, while ectoines (ectoine and OH-ectoine) significantly decrease the lag time. The 
only osmolyte that showed a protective effect by increasing the lag time is taurine. In the methylamines 
class, betaine and sarcosine decrease the lag time. 
Increasing concentrations of osmolytes generally only had a modest effect on the onset of 
fibrillation (Figure 2). The polyols class, which at 125 mM osmolyte showed very little effect, did not 
show any change when the cosolute concentration was doubled or increased up to 400 mM. Increasing 
the amino acids concentration produced only a very modest, and often statistically insignificant, 
decrease in the lag time. Similar behaviour was shown for the methylamines class: the only osmolyte 
that gave a significant reduction of the lag time upon increasing its concentration from 125 to 250 mM 
was sarcosine. 
  Int. J. Mol. Sci. 2012, 13 
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Figure 1. (A) Typical fibrillation kinetic trace in buffer alone and in the presence of the 
osmolytes taurine, OH-ectoine and proline. (B) Lag times for glucagon fibrillation in the 
presence of 125 mM polyols, which leaves glucagon fibrillation mostly unaffected.   
(C) 125 mM of the amino acids and ectoines accelerate glucagon fibrillation, while taurine 
is the only osmolyte that shows a longer lag time compared to the control. (D) 125 mM 
methylamines generally shorten the lag time for glucagon fibrillation.  
 
 
Figure 2. Effect of osmolyte concentration on the lag time for glucagon fibrillation,   
on the different cosolute classes: (A) polyols,  (B) amino acids and their derivatives,   
(C) methylamines. 
 Int. J. Mol. Sci. 2012, 13 
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Figure 2. Cont. 
 
The shape of the ThT time profile showed more variation among the osmolytes than the lag time 
(Figure 1A). Osmolytes with limited ability to change the lag time gave rise to very different fibrillation 
kinetics, as shown by the overshoot parameter O described in Equation 1 (Figure 3). For example, 
proline showed only a 10% reduction in the lag time, while it was able to increase the O factor from 
0.1 to 0.7.  
Figure 3. Effect of 125 mM osmolytes on the appearance of the ThT kinetic traces, as 
shown by the O parameter. 
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The overshoot phenomenon in glucagon fibrillation was first reported by Pedersen et al. [51] and 
confirmed by more recent studies [52]. This overshoot correlated with the transient accumulation of a 
high ThT-staining fibrillation intermediate (type B fibrils), which subsequently interconverts into the 
most stable fibrillar form (low stress or type B fibrils). The shape of the ThT signal can therefore be 
used as an indication of the pathway taken by the fibrillation reaction. A lack of overshoot (seen in the 
absence of osmolytes) is consistent with a lack of type B fibrils; rather, glucagon fibrillates directly to 
the so-called high-stress fibrils [53]. This is a mechanism that was specifically investigated in the case 
of glucagon and might not be transferable to other proteins without prior tests. 
Adding 125 mM amino acids led to an increase of the O factor, with the exception of taurine. The 
more prominent presence of an overshoot was also seen when adding betaine and sarcosine, while the 
polyols left the O factor mostly unaffected. Increasing the polyol concentration led in the case of 
erythritol to an increase in the O factor and a decrease in reproducibility; the other polyols again 
showed no effects even at 400 mM (Figure 4A). Increasing concentrations of Gly, Ala, taurine and 
OH-ectoine gave no additional effect, while Pro and Ser caused a slight decrease in the O factor and 
ectoine a modest increase (Figure 4B). Increasing the concentration of methylamines up to 400 mM 
gave no further change in the O factor (Figure 4C).  
Figure 4. Effect of increasing osmolyte concentrations on the O parameter for (A) polyols, 
(B) amino acids and (C) methylamines. 
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2.2. CD Reveals Glucagon Polymorphism in the Presence of Osmolytes 
To evaluate whether the differences in lag time and overshoot factor indeed could be attributed to 
the formation of different fibrillar types, we acquired CD spectra of the samples in the presence of  
125 mM osmolytes (except for ectoine and OH ectoine where high background absorbance interfered 
with spectral recording).  
All our fibrillation studies are carried out under agitated conditions (shaking at 720 rpm). 
Accordingly, the osmolyte-free fibrils show the β-sheet like spectrum observed for glucagon fibrils in 
the presence of high mechanical stress [54] with a negative peak at 215 nm and a positive peak at  
232 nm, that we attribute to aromatic contributions to the CD spectrum [55]. Adding polyols not only 
leaves the ThT traces unaffected, as shown both for the lag time and the O parameter, but also shows 
almost no effect on the CD spectra, except for a small red-shift of the minimum and reduction of the 
intensity of minimum and maximum in the presence of glucose (Figure 5A).  
Figure 5. CD spectra of glucagon samples in the presence of 125 mM (A) polyols,   
(B) amino acids and (C) methylamines. It was not possible to acquire CD spectra of the 
ectoine samples, as their absorbance saturated the detector, while strong dilution would not 
allow the fibril detection. The three replica wells of the choline-O-sulfate (COS) samples 
are displayed as they showed different spectra which correlated with their fibrillation traces 
(panel D).  
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Adding amino acids or their derivatives dramatically changes the fibrils’ morphology (Figure 5B). 
Despite the high degree of shaking, Pro and Ser lead to CD spectra typical of glucagon fibrils in the 
presence of low mechanical stress [54], also known as type B fibrils [43], with a positive peak at  
203 nm and a negative peak at 230 nm. Remarkably, Ala shows a spectrum typical of type D fibrils [43] 
grown in the presence of high NaCl concentration, characterized by a broad minimum at around 220 nm. 
Gly was previously used at 50 mM (pH 2.5) as standard buffer in previous studies [43,54,56], but  
175 mM Gly made glucagon fibrillate into a β-sheet-like structure, with a shoulder at around 225 nm; 
taurine instead shows the same CD spectrum as the control (negative peak at 215 nm and a positive 
peak at 232 nm).  
The methylamines created variations in the spectra as well: while betaine shows a spectrum identical 
to osmolyte-free glucagon, sarcosine shows a low stress type B spectrum. An anomalous behaviour 
was shown only in the case of Choline-O-Sulfate (COS): the three replica wells showed different 
spectra (Figure 5C) which tie in with the variation in the kinetic time profiles (Figure 5D). Two of the 
three wells gave the low stress fibrillar type, though with different peak intensities, while the third well 
shows a flat spectrum with a very shallow minimum at 218 nm, which remains at MRE values just 
below zero up to 250 nm.  
The effects of the osmolytes, both in terms of kinetics and structure are summarized in Table 1 
(column “Glucagon”). 
3. Discussion 
In this study we have examined the effect of osmolytes on glucagon fibrillation. Glucagon is a short 
peptide lacking a folded native structure; for the peptide to aggregate, we have previously proposed 
that a partially folded intermediate must form in which residues 6–10 and 23–27 come in close vicinity 
to each other [57]. Thus fibrillation requires the peptide to become more compact. We observe that 
different types of osmolytes cannot inhibit aggregation, similarly to results reported for other intrinsically 
disordered proteins, such as Aβ and tau [22,24]. With few exceptions, osmolytes promote faster 
fibrillation of glucagon or have no effect at all. Exceptions also occur for other peptides and proteins: 
trehalose was able to inhibit Aβ fibrillation [36] while polyols slowed down the fibrillation of   
insulin [14]. The only osmolyte that showed a delay of glucagon’s fibrillation onset and no effect on 
glucagon fibrillar morphology is the amino acid derivative taurine, which was previously reported to 
accelerate Aβ aggregation [35] and to generally promote protein compaction [15]. Other amino acids 
derivatives, such as ectoine, had the opposite effect to taurine. Thus the same osmolyte can have 
different effects depending on the specific protein used in the study.  
Each protein can therefore have a reduced or increased tendency to fibrillate, depending on the 
osmolyte used. Some osmolytes indeed have similar effects on very different proteins. The polyol 
fructose has no effect on the aggregation behaviour of folded proteins as insulin [14] or the 
unstructured peptide Aβ [24], while osmolytes such as trehalose and TMAO mostly show inhibitory 
effects on the formation of amyloid-like fibrils formed by different proteins (Table 1).  
Osmolytes belonging to the polyol class showed very little or no effect on glucagon fibrillation 
kinetics and CD spectra, even though they are reported to be most effective at low pH [8], as used in 
this study. Amino acids and methylamines on the other hand showed an effect both on the fibrillation Int. J. Mol. Sci. 2012, 13 
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kinetics and on the fibrils’ structure. Moreover, methylamines are reported to destabilize at low   
pH [15], and in this study they lead to faster aggregation of glucagon. Amino acids are thought to 
balance hydration (preferential exclusion) and binding effects. In particular, the polyols class is   
known to act through these hydration effects. However, these effects clearly have little influence on  
the fibrillation of glucagon. This leaves osmolyte binding as a possible mediator of glucagon   
fibril polymorphism. 
The overshoot factor was a more sensitive detector than the lag time for the presence of different 
fibrillar morphologies for the different samples analyzed. For example, while Pro showed a 10% 
reduction of the lag time, changing completely the CD spectrum (O parameter going from 0.1 in the 
absence of osmolyte to 0.7 in the presence of Pro), mannitol showed a 15% reduction of the lag time, 
but left the O parameter and the CD spectrum unaffected. Generally, an O parameter <0.4 leads to an 
osmolyte-free CD spectrum while O parameters >0.4 changes the morphology towards other fibrillar 
types, such as the low stress (also known as type B) and type D fibrils [43]. In the case of COS there is 
a particularly close correlation between the shape of the curve and the resulting morphology. This 
osmolyte gives the lowest reproducibility, both in terms of lag time and overshoot factor, and different 
kinetic profiles (Figure 5D) lead to different fibril morphologies according to CD spectra (Figure 5C). 
The role of the osmolytes on the selection of the fibril structure is a fascinating issue. Pro, Ser and 
COS modify the structure of glucagon fibrils from the typical structure in the presence of high 
mechanical stress to the one present in the exact same conditions, but under low stress. This can be 
rationalized by a protection effect exerted by the osmolytes on glucagon, “shielding” the effect of 
mechanical perturbation, particularly as amino acids preferentially bind to proteins [8] (Figure 6). This 
would happen as osmolytes could allow the formation of the labile intermediate, which is required for 
the formation of low stress fibrils, even under high stress conditions, in which the formation of the 
labile intermediate is normally inhibited and therefore leads to another type of fibril [54]. 
Figure 6. Suggested fibrillation mechanism. Left panel: the absence of osmolytes leads to 
high stress (HS) fibrils. Right panel: the presence of Pro, Ser or COS is suggested to lead to 
the formation of the labile type A intermediate as the osmolytes bind glucagon, “shielding” 
it from the high stress conditions. The resulting fibrils are here called low stress (LS). 
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It is difficult to explain the appearance of the type D fibrils in the presence of Ala and sarcosine, but 
we suggest that specific interactions between the peptide and these chemical chaperones could 
intervene in the fibrillation process, thus leading to another structure. 
The very low concentration dependence on the effect of osmolytes generally makes their effect 
resemble electrostatic interactions where the effect saturates at an ionic strength corresponding to   
100–200 mM, rather than a crowding effect, for which increasing osmolyte concentration will have a 
increasing effect at concentrations up to several molar [58,59]. 
In summary, it is evident that neither osmolytes in general nor those belonging to a particular 
compound class influence glucagon aggregation in a uniform manner. The distinct effects of compounds 
such as taurine, COS or Ala more likely result from direct interaction of the compounds with the 
protein than from non-specific solvent effects. Direct interaction might also be the reason for effects 
observed here that are not consistent with other published work, simply because they could be   
protein-specific. Since the molecular basis of aggregation is diverse, more model systems able to 
distinguish between those pathways will be needed to obtain a clearer picture. Also, larger sets of 
osmolytes as well as model proteins need to be screened to draw conclusions on their general 
mechanism of action, due to the specificity of some osmolyte-protein interactions. 
4. Experimental Section  
4.1. Glucagon Fibrillation in the Plate Reader 
Glucagon powder was dissolved in 10 mM HCl (pH 2) and filtered through a 0.2 µm filter. The actual 
glucagon concentration in solution was determined from absorbance measurements on a Nanodrop 
(Thermo Fisher Scientific, Waltham, MA) using an extinction coefficient ε280 nm
1mg/mL = 2.369. The 
stock solution was subsequently diluted in 50 mM Gly buffer pH 2.5 containing 40 µM ThT, with or 
without the presence of osmolytes, to a final glucagon concentration of 1 mg/mL. 
Solutions were transferred to a 96 wells plate with transparent bottoms for fluorescence reading 
(Nunc, Thermo Scientific, Roskilde, Denmark), sealed with transparent tape (Nunc) to avoid 
evaporation. Each condition was present in three replica wells. 
The plates were incubated in a Tecan GeniosPro plate reader at 29 °C. ThT emission was measured 
(excitation wavelength 448 nm, emission 485 nm) every 10 min. During each interval linear shaking 
was performed at 720 rpm for 8 min. 
To analyze the kinetic profiles, we extracted the lag time for all samples. The lag time was defined 
as the time required for the development of 5% of the maximum fluorescence intensity. We also 
calculated an overshoot factor O using the following equation: 
 
(1)
in which M is the maximum ThT fluorescence, i is the initial ThT fluorescence and E is the end 
point fluorescence value, in order to describe the shape of the kinetic trace, where O = 0 indicates the 
complete absence of overshoot and O = 1 an overshoot that leads back to the initial intensity value. 
Errors were calculated as standard deviations. 
   
O M E
M iInt. J. Mol. Sci. 2012, 13 
 
 
3815
4.2. Circular Dichroism 
Fibrillated glucagon samples with or without osmolyte presence were sonicated for 2 s with a 
Bandelin Sonopuls sonicator (Bandelin Electronic GmbH, Germany) to disperse aggregates efficiently, 
and subsequently diluted to a final concentration of 0.2 mg/mL glucagon in 25 mM glycine buffer.  
The samples were measured on a Jasco J-810 (Tokyo, Japan) spectrometer using a 1 mm quartz 
cuvette (Hellma GmbH, Germany). At least 5 accumulations were acquired, using a scanning   
speed of 100 nm/min and 0.2 nm data pitch. The data are reported as Mean Residue Ellipticity:   
MRE = 100θ/(cdN), where θ is the measured ellipticity in degrees, c is the protein concentration in 
mol/L, d is the light path in cm, and N is the number of residues. Background spectra including 
appropriate concentrations of osmolytes are subtracted from each spectrum. 
The CD spectrum shown for the control is the one reported for glucagon in the presence of high 
mechanical stress [54]. Unlike the previous study [54], no glass bead was added. We attribute the 
formation of high stress fibrils to the usage of a new protein batch compared to the two batches used 
previously [54]. To facilitate comparison, all experiments were performed with the same batch. 
5. Conclutions 
It is evident that neither osmolytes in general nor those belonging to a particular compound class 
influence glucagon aggregation in a uniform manner. The distinct effects of compounds such as 
taurine, COS or Ala more likely result from direct interaction of the compounds with the protein than 
from non-specific solvent effects. Direct interaction might also be the reason for effects observed here 
that are not consistent with other published work, simply because they could be protein-specific. Since 
the molecular basis of aggregation is diverse, more model systems able to distinguish between those 
pathways will be needed to obtain a clearer picture. Also, larger sets of osmolytes as well as model 
proteins need to be screened to draw conclusions on their general mechanism of action, due to the 
specificity of some osmolyte-protein interactions. 
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